ReviewImmune network2024

Exploring the Potential of Glycolytic Modulation in Myeloid-Derived Suppressor Cells for Immunotherapy and Disease Management.

Jisu Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.